ALIS
We're Hiring!
ALIS Company Growth, Stability & Outlook
What People Are Saying About ALIS
-
Product Line Growth: ALIS launched "Ask ALIS" with general availability targeted for Q1 2026 and emphasizes a unified platform spanning clinical/eMAR, CRM/RevOps, billing, BI, and new benchmarking products like the ALIS 500.
-
Strategic Partnerships: New and expanding integrations (e.g., CarePredict, PalCare) and a catalog highlighting 130+ partners, along with collaborations such as NIC’s Actual Rates program, point to a strengthening ecosystem and increased stickiness.
-
Innovation-Driven Growth: The embedded AI assistant and recurring ALIS 500 benchmarking series demonstrate ongoing investment in AI and data capabilities designed to differentiate the product and enhance operator value.
